ALL
FDA Grants Accelerated Approval to Iclusig With Chemotherapy for Newly Diagnosed Ph+ ALL
The FDA granted accelerated approval to Iclusig with chemotherapy for adult patients with newly diagnosed ...
MARCH 20, 2024
BiTE Therapy Shows Promise in R/R ALL
Although only a phase 1b dose-finding study in patients with relapsed/refractory (R/R) B-cell precursor acute ...
MARCH 16, 2022
Studies Point to Optimal Dosing in Acute Leukemia and Lymphoma
Two new studies of drugs already licensed for cancer—one indicated for ALL and one approved for both ALL and ...
JANUARY 18, 2022
Managing Asparaginase Hypersensitivity Reactions
Asparaginase-based regimens are gaining a foothold in the treatment of acute lymphoblastic leukemia (ALL) and ...
JANUARY 14, 2022
Load more